Suchergebnisse - "Cavallari, Larisa H"

PubPharm (293)

51

Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators

enthalten in: Clinical and Translational Science | 2022

von Cavallari, L. | Cicali, E. | Wiisanen, K. | +36

52

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy

enthalten in: Clinical and Translational Science | 2022

von Tuteja, S. | Salloum, R. | Elchynski, A. | +25

53

β1‐receptor polymorphisms and junctional ectopic tachycardia in children after cardiac surgery

enthalten in: Clinical and Translational Science | 2022

von Dumeny, L. | Chantra, M. | Langaee, T. | +14

54

A randomized, cross‐over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence

enthalten in: Clinical and Translational Science | 2022

von Mosley, S. | Kim, S. | El Rouby, N. | +18

55

How to implement a pharmacogenetics service at your institution

enthalten in: Journal of the American College of Clinical Pharmacy | 2022

von Cicali, E. | Lemke, L. | Al Alshaykh, H. | +3

56

Pharmacogenetics : A precision medicine approach to combatting the opioid epidemic

enthalten in: Journal of the American College of Clinical Pharmacy | 2022

von Smith, D. | Stevenson, J. | Ho, T. | +3

57

Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing

enthalten in: Genetics in medicine : official journal of the American College of Medical Genetics | 2021

von Duarte, J. | Dalton, R. | Elchynski, A. | +19

58

Corrigendum to "Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar : A Prospective Cohort Study". [Current Problems in Cardiology Volume 46, Issue 6, June 2021, 100816

enthalten in: Current problems in cardiology | 2021

von Eljilany, I. | Shallik, N. | Elarref, M. | +8

ErratumFor: Curr Probl Cardiol. 2021 Jun;46(6):100816. - PMID 33721568

59

NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo-DHF trial

enthalten in: Pharmacotherapy | 2021

von Dumeny, L. | Vardeny, O. | Edelmann, F. | +3

60

Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease

enthalten in: The pharmacogenomics journal | 2021

von Elchynski, A. | Cicali, E. | Ferrer Del Busto, M. | +10